Recently, a Cox regression model based on age, AST/ALT-ratio, and ALT-level (dAAR) was reported to predict the risk of incident severe liver outcomes in the general population and may be of value for detecting advanced liver fibrosis [87]. This evidence concerns the gene GPT and Hepatic fibrosis.